Atlas One · Host Biology · Scale 07 — System

Ovarian Clear Cell Carcinoma

Ovarian clear cell carcinoma (OCCC) is an endometriosis-derived subtype; ARID1A (~50%) and PIK3CA (~50%) are hallmark mutations; platinum-resistant; no FDA-approved targeted therapy; higher incidence in Asian women; mTOR inhibitors and EZH2 inhibitors under investigation.

Also known as: OCCC, ovarian clear cell carcinoma, clear cell ovarian cancer, endometriosis-associated ovarian cancer, ARID1A ovarian cancer, PIK3CA ovarian clear cell, clear cell adenocarcinoma ovary, endometrioid-related ovarian cancer, ovarian cancer clear cell, CCC ovarian

Scale 07 — SystemScale
draftStatus
2026-06-07Last Reviewed
This is an auto-generated stub page built from atlas entry frontmatter. A richer hand-crafted page is planned. See the atlas source for the full entry including detailed body sections.
ovarian-clear-cell-carcinoma

Ovarian Clear Cell Carcinoma

Ovarian clear cell carcinoma (OCCC) is an endometriosis-derived subtype; ARID1A (~50%) and PIK3CA (~50%) are hallmark mutations; platinum-resistant; no FDA-approved targeted therapy; higher incidence in Asian women; mTOR inhibitors and EZH2 inhibitors under investigation.